Mark Shahram Shahin MD FACOG, FACS (He/Him)
Gynecologic Oncology
Chief Surgical Officer, Alliance Cancer Specialists. The US Oncology Network
Join to View Full Profile
500 University DrHershey, PA 17033
Phone+1 717-531-3503
Fax+1 717-531-0117
Dr. Shahin is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Mark Shahin, MD, is an Obstetrics and Gynecology specialist with a subspecialty in Gynecologic Oncology, based in Hershey, PA. He completed his medical education at Northwestern University The Feinberg School of Medicine and underwent residency and fellowship training at McGaw Medical Center and University of Iowa Hospitals and Clinics, respectively. Dr. Shahin is the Director at Jefferson Abington Health and a Professor at Thomas Jefferson University Hospital. His research and clinical interests include ovarian neoplasms, fallopian tube carcinoma, and general gynecology. He has been the principal investigator in notable clinical trials and published extensively on gynecologic oncology. His work has been recognized with several honors, including certifications from eClinicalWorks and listings in Philadelphia Magazine.
Education & Training
University of Iowa Hospitals and ClinicsFellowship, Gynecologic Oncology, 1997 - 1998
McGaw Medical Center of Northwestern UniversityResidency, Obstetrics and Gynecology, 1993 - 1997- Northwestern University The Feinberg School of MedicineClass of 1993
Certifications & Licensure
PA State Medical License 2001 - 2026
IA State Medical License 1997 - 2003
IL State Medical License 1993 - 1999
American Board of Obstetrics and Gynecology Obstetrics & Gynecology- American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification eClinicalWorks, eClinicalWorks, LLC, 2014-2017
- CMS Meaningful Use Stage 2 Certification eClinicalWorks, eClinicalWorks, LLC, 2014-2017
- Philadelphia Magazine Castle Connolly, 2011-2016
Clinical Trials
- Seprafilm® for Prevention of Adhesions at Repeat Cesarean Start of enrollment: 2008 Jul 01
- A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer Start of enrollment: 2020 Sep 01
Roles: Principal Investigator, Contact
- A Comparison of Exparel to Bupivacaine in TAP Block for Abdominal Gynecologic Surgery Start of enrollment: 2016 Aug 01
Roles: Contact
Publications & Presentations
PubMed
- Updated patient-reported outcomes and the effect of disease progression on health-related quality of life in the PRIMA/ENGOT-OV26/GOG-3012 trial of niraparib first-lin...Mark S Shahin, Domenica Lorusso, Floor J Backes, Maria-Pilar Barretina-Ginesta, David M O'Malley
Gynecologic Oncology. 2026-07-01 - Impact of preoperative frailty assessment on peri-operative complications and cancer related outcomes in advanced stage endometrial cancer.Christine I Cho, Anne-Laure Strong, Brooke Arner, Christina Stetter, Edward Podczaski
Gynecologic Oncology Reports. 2026-06-01 - 1 citationsComparative outcomes of nab-paclitaxel and paclitaxel in platinum-resistant ovarian cancer (COMPASS).Mark S Shahin, Raina Mathur, Anju Parthan, Prakirthi Yerram, Amanda Kesner-Hays
Gynecologic Oncology. 2026-01-01
Press Mentions
SGO Hosts Women’s Health Advocacy Events in the Nation’s CapitalFebruary 20th, 2025
'I Think About the Lives Saved': What We Heard This WeekMarch 22nd, 2019
Professional Memberships
- Fellow
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
